Innovations in the new CV risk-assessment guidelines, which were released today by the ACC and AHA, reflect a focus on atherosclerosis as a chronic disease that extends beyond the heart [1].

Higher resting heart rate (HR) and increases in HR over time are associated with increased risk of adverse cardiovascular (CV) and non-CV events, according to a study published in JAMA Cardiology ...

Key takeaways: Ischemic stroke was the most frequent CV event among patients with syphilis. Patients with syphilis had increased risk for CV death and all-cause mortality during 5 years of follow ...

Using propensity score matching, Chen and colleagues compared CV outcomes in 1,250 adults with type 2 diabetes from the National Health Insurance Research Database who received vildagliptin ...

The principal findings showed that compared with patients who took placebo, those who were randomized to empagliflozin had a 38% (P <0.001) reduced risk of CV death and a 35% P =0.002) reduced ...

Findings showed that when compared with placebo, treatment with finerenone reduced the incidence of the primary composite endpoint of CV death, nonfatal MI, nonfatal stroke or hospitalization for ...